🇺🇸 FDA
Pipeline program

BAT5906 injection

BAT5906-005-CR

Phase 3 small_molecule active

Quick answer

BAT5906 injection for Diabetic Macular Edema (DME) is a Phase 3 program (small_molecule) at Bio-Thera Solutions with 1 ClinicalTrials.gov record(s).

Program details

Company
Bio-Thera Solutions
Indication
Diabetic Macular Edema (DME)
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials